Nathan Schramm
Corneal and Contact Management · Costa Mesa, CANPI 1265682876
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.2%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 23.1%. Reporting peaked in 2024 at $14,769 and has fallen 76.3% since, to $3,499 in 2025. Among corneal and contact management clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $219.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb, A Division Of Bausch Health US, LLC$8K
- Tarsus Pharmaceuticals, Inc.$6K
- Visionary Optics LLC$5K
- Visioneering Technologies, Inc.$5K
- Bausch & Lomb Americas Inc.$2K
- Glaukos Corporation$1K
- plus $6K from 19 others
What the payments were for
- Consulting fees$5,19815%
- Speaking & faculty fees$5,70017%
- Travel & lodging$1,4614%
- Food & beverage$16,32348%
- Gifts$5,07515%
- Entertainment$850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 9 | $7,832 |
| Tarsus Pharmaceuticals, Inc. | 8 | $5,750 |
| Visionary Optics LLC | 5 | $5,323 |
| Visioneering Technologies, Inc. | 3 | $4,862 |
| Bausch & Lomb Americas Inc. | 41 | $2,422 |
| Glaukos Corporation | 13 | $1,443 |
| Alcon | 10 | $905 |
| Oyster Point Pharma, Inc. | 11 | $736 |
| Sight Sciences, Inc. | 8 | $688 |
| Harrow Eye, LLC | 6 | $592 |
| Johnson & Johnson Vision Care, Inc. | 12 | $576 |
| Coopervision Inc. | 9 | $534 |
| Astellas Pharma US Inc | 3 | $384 |
| Apellis Pharmaceuticals, Inc. | 3 | $356 |
| Lombart Brothers, Inc. | 1 | $286 |
| Lumenis BE Inc | 1 | $266 |
| Dompe US, Inc. | 2 | $228 |
| Ocular Therapeutix, Inc. | 1 | $143 |
| Eyevance Pharmaceuticals LLC | 1 | $138 |
| Novartis | 2 | $122 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $100 |
| Optos, Inc. | 1 | $85 |
| Visionix USA, Inc | 1 | $31 |
| Thea Pharma Inc. | 1 | $24 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$33,841 in reported general payments places this provider in the 95th percentile of 140 corneal and contact management providers in California.
See all corneal and contact management providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TyrvayaVarenicline Tartrate | 24 | $18,079 |
| XiidraLifitegrast | 15 | $15,179 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Oyster Point Pharma, Inc.Tyrvaya | $736 | $18,07924 claims |
| Bausch & Lomb Americas Inc.Xiidra | $2,422 | $15,17915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 140 corneal and contact management providers in California.
Other corneal and contact management in Costa Mesa
- Jeffrey BrownCosta Mesa$2K
- Milton HomAzusa$762K
- Kambiz SilaniBeverly Hills$123K
- Gloria ChiuLos Angeles$80K
- John GellesSunnyvale$37K
- Jasdeep SoniBakersfield$26K
- Arti ShahCerritos$20K
- Gregory TomSan Ramon$16K
- Jay MashoufSan Diego$14K
- Ruth TangIrvine$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.